Is this common supplement safe Long-Term? new study aims to find out
NCT ID NCT06717867
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests the long-term safety of a supplement called palmitoylethanolamide (PEA) in 200 healthy adults aged 18 and older. Participants take either PEA or a placebo daily for 12 months and attend check-ups to monitor side effects, vital signs, and blood work. The goal is simply to see if long-term use is safe, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RDC Clinical
RECRUITINGBrisbane, Queensland, 4006, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.